Apremilast Therapy for Acute Gouty Arthritis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Acute Gout
Interventions
DRUG

apremilast

apremilast 20 mg taken twice daily by mouth

DRUG

indomethacin SR

indomethacin SR 75 mg taken twice daily by mouth

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER